亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
耶子完成签到 ,获得积分10
36秒前
Kao应助科研通管家采纳,获得10
39秒前
39秒前
eyes完成签到,获得积分10
51秒前
杨晓白完成签到,获得积分10
1分钟前
XP完成签到 ,获得积分10
1分钟前
OtterMester完成签到,获得积分10
1分钟前
877633629完成签到 ,获得积分10
1分钟前
2分钟前
希望天下0贩的0应助thanks采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
OK应助科研通管家采纳,获得20
2分钟前
2分钟前
2分钟前
茗好发布了新的文献求助10
2分钟前
BW发布了新的文献求助10
2分钟前
2分钟前
深情安青应助小透明采纳,获得10
2分钟前
酷波er应助小透明采纳,获得30
2分钟前
Ava应助小透明采纳,获得10
2分钟前
2分钟前
小透明发布了新的文献求助10
3分钟前
我是老大应助BW采纳,获得10
3分钟前
3分钟前
说话的月亮完成签到,获得积分10
3分钟前
科研通AI6.2应助吕怡水采纳,获得10
3分钟前
3分钟前
子訡完成签到 ,获得积分10
3分钟前
吕怡水完成签到,获得积分10
3分钟前
牧野小曾完成签到,获得积分10
3分钟前
吕怡水发布了新的文献求助10
3分钟前
3分钟前
朱志伟发布了新的文献求助10
3分钟前
风中的香寒完成签到 ,获得积分10
3分钟前
朱志伟完成签到,获得积分10
3分钟前
3分钟前
sujiaoziemo完成签到,获得积分10
3分钟前
所所应助sujiaoziemo采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
《上海印钞厂志》 3000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7338450
求助须知:如何正确求助?哪些是违规求助? 8951904
关于积分的说明 18998491
捐赠科研通 6991154
什么是DOI,文献DOI怎么找? 3218386
关于科研通互助平台的介绍 2384154
邀请新用户注册赠送积分活动 2198365